ONSET, EVOLUTION AND TREATMENT RESPONSE IN PATIENTS WITH INDOLENT LYMPHOMAS – CASE REPORTS

June 1, 2012

Ciobanu Anca 1, Triantafyllidis Irina 2, Stanca Oana 2
1 Hematology Clinic, Coltea Clinical Hospital, Bucharest, Romania
2 UMF “Carol Davila” Bucharest – Hematology Department, Coltea Clinical Hospital, Bucharest, Romania

Abstract

Indolent lymphomas are malignant tumors of the cells of the immune system, located in different tissues. The clinical evolution is unpredictable, some cases going well beyond the average rate of survival of 8-10 years, and others with an increased probability of transforming into lymphomas with high malignancy. Based on the data provided in literature, we shall describe three cases diagnosed with indolent lymphomas focusing on the type of onset, evolution and treatment response.

Previous Story

ESTIMATED SODIUM CONTENT IN PRESCRIPTION MEDICATION: GIVING HEALTHCARE PROVIDERS INFORMATION ON THE ESTIMATED SODIUM CONTENT IN PRESCRIPTION MEDICATIONS IN AN EASY-TO-USE FORMAT

Next Story

HIGH – FLOW PRIAPISM IN A PEDIATRIC PATIENT. A CASE REPORT